» Articles » PMID: 25429779

Effect of Curcumin in Mice Model of Vincristine-induced Neuropathy

Overview
Journal Pharm Biol
Specialties Pharmacology
Pharmacy
Date 2014 Nov 29
PMID 25429779
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Curcumin exhibits a wide spectrum of biological activities which include neuroprotective, antinociceptive, anti-inflammatory, and antioxidant activity.

Objective: The present study evaluates the effect of curcumin in vincristine-induced neuropathy in a mice model.

Materials And Methods: Vincristine sulfate (0.1 mg/kg, i.p. for 10 consecutive days) was administered to mice to induce neuropathy. Pain behavior was assessed at different days, i.e., 0, 7, 10, and 14 d. Sciatic nerve total calcium, superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), reduced glutathione (GSH), nitric oxide (NO), and lipid peroxidation (LPO) were also estimated after the 14th day of study. Pregabalin (10 mg/kg, p.o.) and curcumin (15, 30, and 60 mg/kg, p.o.) were administered for 14 consecutive days.

Results: Curcumin at 60 mg/kg significantly attenuated the vincristine-induced neuropathic pain manifestations in terms of thermal hyperalgesia (p < 0.001) and allodynia (p < 0.001); mechanical hyperalgesia (p < 0.001); functional loss (p < 0.001); and in the delayed phase of formalin test (p < 0.001). Curcumin at 30 and 60 mg/kg exhibited significant changes (p < 0.001) in antioxidant levels and in total calcium levels in vincristine-injected mice.

Conclusion: Curcumin at 30 and 60 mg/kg dose levels significantly attenuated vincristine-induced neuropathy which may be due to its multiple actions including antinociceptive, calcium inhibitory, and antioxidant effect.

Citing Articles

The effect of oral curcumin on vincristine-induced neuropathy in pediatric acute lymphoblastic leukemia: A double-blind randomized controlled clinical trial.

Eghbali A, Adibifar M, Ghasemi A, Afzal R, Moradi K, Eghbali A BMC Cancer. 2025; 25(1):344.

PMID: 40000988 PMC: 11853498. DOI: 10.1186/s12885-025-13751-7.


Phytochemical-based therapeutics from traditional eastern medicine: analgesic effects and ion channel modulation.

Kim S, Chung G, Kim S Front Pain Res (Lausanne). 2025; 6:1537154.

PMID: 39958366 PMC: 11825757. DOI: 10.3389/fpain.2025.1537154.


Unlocking New Therapeutic Options for Vincristine-Induced Neuropathic Pain: The Impact of Preclinical Research.

Puscasu C, Negres S, Zbarcea C, Chirita C Life (Basel). 2024; 14(11).

PMID: 39598298 PMC: 11595627. DOI: 10.3390/life14111500.


Protective effect of oxytocin on vincristine-induced gastrointestinal dysmotility in mice.

Li S, Shi Y, Zhu J, Li J, Wang S, Liu C Front Pharmacol. 2024; 15:1270612.

PMID: 38655179 PMC: 11037254. DOI: 10.3389/fphar.2024.1270612.


Animal models of chemotherapy-induced peripheral neuropathy for hematological malignancies: A review.

Lv X, Mao Y, Cao S, Feng Y Ibrain. 2023; 9(1):72-89.

PMID: 37786517 PMC: 10529012. DOI: 10.1002/ibra.12086.